| node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
| KXA31358.1 | ndoA | HMPREF3229_00472 | HMPREF3229_00621 | SpoVT/AbrB-like protein; KEGG: zro:ZYRO0D08822g 0.0095 hypothetical protein; K14644 subtilase-type proteinase RRT12; Psort location: Cytoplasmic, score: 7.50. | Toxin-antitoxin system, toxin component, MazF family; Toxic component of a type II toxin-antitoxin (TA) system. | 0.967 |
| ndoA | KXA31358.1 | HMPREF3229_00621 | HMPREF3229_00472 | Toxin-antitoxin system, toxin component, MazF family; Toxic component of a type II toxin-antitoxin (TA) system. | SpoVT/AbrB-like protein; KEGG: zro:ZYRO0D08822g 0.0095 hypothetical protein; K14644 subtilase-type proteinase RRT12; Psort location: Cytoplasmic, score: 7.50. | 0.967 |
| ndoA | nnr_1 | HMPREF3229_00621 | HMPREF3229_00622 | Toxin-antitoxin system, toxin component, MazF family; Toxic component of a type II toxin-antitoxin (TA) system. | Holo-[acyl-carrier-protein] synthase; Catalyzes the dehydration of the S-form of NAD(P)HX at the expense of ADP, which is converted to AMP. Together with NAD(P)HX epimerase, which catalyzes the epimerization of the S-and R-forms, the enzyme allows the repair of both epimers of NAD(P)HX, a damaged form of NAD(P)H that is a result of enzymatic or heat-dependent hydration. Belongs to the NnrD/CARKD family. | 0.613 |
| ndoA | tagA | HMPREF3229_00621 | HMPREF3229_00620 | Toxin-antitoxin system, toxin component, MazF family; Toxic component of a type II toxin-antitoxin (TA) system. | Glycosyltransferase, WecB/TagA/CpsF family; Catalyzes the conversion of GlcNAc-PP-undecaprenol into ManNAc-GlcNAc-PP-undecaprenol, the first committed lipid intermediate in the de novo synthesis of teichoic acid. | 0.515 |
| ndoA | tkt | HMPREF3229_00621 | HMPREF3229_00619 | Toxin-antitoxin system, toxin component, MazF family; Toxic component of a type II toxin-antitoxin (TA) system. | Transketolase; Catalyzes the transfer of a two-carbon ketol group from a ketose donor to an aldose acceptor, via a covalent intermediate with the cofactor thiamine pyrophosphate. | 0.436 |
| nnr_1 | ndoA | HMPREF3229_00622 | HMPREF3229_00621 | Holo-[acyl-carrier-protein] synthase; Catalyzes the dehydration of the S-form of NAD(P)HX at the expense of ADP, which is converted to AMP. Together with NAD(P)HX epimerase, which catalyzes the epimerization of the S-and R-forms, the enzyme allows the repair of both epimers of NAD(P)HX, a damaged form of NAD(P)H that is a result of enzymatic or heat-dependent hydration. Belongs to the NnrD/CARKD family. | Toxin-antitoxin system, toxin component, MazF family; Toxic component of a type II toxin-antitoxin (TA) system. | 0.613 |
| nnr_1 | tagA | HMPREF3229_00622 | HMPREF3229_00620 | Holo-[acyl-carrier-protein] synthase; Catalyzes the dehydration of the S-form of NAD(P)HX at the expense of ADP, which is converted to AMP. Together with NAD(P)HX epimerase, which catalyzes the epimerization of the S-and R-forms, the enzyme allows the repair of both epimers of NAD(P)HX, a damaged form of NAD(P)H that is a result of enzymatic or heat-dependent hydration. Belongs to the NnrD/CARKD family. | Glycosyltransferase, WecB/TagA/CpsF family; Catalyzes the conversion of GlcNAc-PP-undecaprenol into ManNAc-GlcNAc-PP-undecaprenol, the first committed lipid intermediate in the de novo synthesis of teichoic acid. | 0.448 |
| tagA | ndoA | HMPREF3229_00620 | HMPREF3229_00621 | Glycosyltransferase, WecB/TagA/CpsF family; Catalyzes the conversion of GlcNAc-PP-undecaprenol into ManNAc-GlcNAc-PP-undecaprenol, the first committed lipid intermediate in the de novo synthesis of teichoic acid. | Toxin-antitoxin system, toxin component, MazF family; Toxic component of a type II toxin-antitoxin (TA) system. | 0.515 |
| tagA | nnr_1 | HMPREF3229_00620 | HMPREF3229_00622 | Glycosyltransferase, WecB/TagA/CpsF family; Catalyzes the conversion of GlcNAc-PP-undecaprenol into ManNAc-GlcNAc-PP-undecaprenol, the first committed lipid intermediate in the de novo synthesis of teichoic acid. | Holo-[acyl-carrier-protein] synthase; Catalyzes the dehydration of the S-form of NAD(P)HX at the expense of ADP, which is converted to AMP. Together with NAD(P)HX epimerase, which catalyzes the epimerization of the S-and R-forms, the enzyme allows the repair of both epimers of NAD(P)HX, a damaged form of NAD(P)H that is a result of enzymatic or heat-dependent hydration. Belongs to the NnrD/CARKD family. | 0.448 |
| tagA | tkt | HMPREF3229_00620 | HMPREF3229_00619 | Glycosyltransferase, WecB/TagA/CpsF family; Catalyzes the conversion of GlcNAc-PP-undecaprenol into ManNAc-GlcNAc-PP-undecaprenol, the first committed lipid intermediate in the de novo synthesis of teichoic acid. | Transketolase; Catalyzes the transfer of a two-carbon ketol group from a ketose donor to an aldose acceptor, via a covalent intermediate with the cofactor thiamine pyrophosphate. | 0.661 |
| tkt | ndoA | HMPREF3229_00619 | HMPREF3229_00621 | Transketolase; Catalyzes the transfer of a two-carbon ketol group from a ketose donor to an aldose acceptor, via a covalent intermediate with the cofactor thiamine pyrophosphate. | Toxin-antitoxin system, toxin component, MazF family; Toxic component of a type II toxin-antitoxin (TA) system. | 0.436 |
| tkt | tagA | HMPREF3229_00619 | HMPREF3229_00620 | Transketolase; Catalyzes the transfer of a two-carbon ketol group from a ketose donor to an aldose acceptor, via a covalent intermediate with the cofactor thiamine pyrophosphate. | Glycosyltransferase, WecB/TagA/CpsF family; Catalyzes the conversion of GlcNAc-PP-undecaprenol into ManNAc-GlcNAc-PP-undecaprenol, the first committed lipid intermediate in the de novo synthesis of teichoic acid. | 0.661 |